Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review

Vikram Narayan, Philipp Dahm, Nicole Skoetz, Michael C. Risk, Connie Bongiorno, Neil Patel, Jae Hung Jung, Gerald Gartlehner, Frank Kunath

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of pembrolizumab monotherapy versus chemotherapy for the second-line treatment of advanced urothelial carcinoma.

Original languageEnglish (US)
Article numberCD012838
JournalCochrane Database of Systematic Reviews
Volume2017
Issue number11
DOIs
StatePublished - Nov 1 2017

Fingerprint Dive into the research topics of 'Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review'. Together they form a unique fingerprint.

Cite this